A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001161:Arteriosclerosis / Q000188:drug therapy; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging; D005684:Gait; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D009991:Oscillometry; D011674:Pulse; D011727:Pyridinolcarbamate / Q000627:therapeutic use; D011859:Radiography; D012881:Skin Temperature; D012907:Smoking; D013919:Thromboangiitis Obliterans / Q000188:drug therapy
D002219:Carbamates; D000960:Hypolipidemic Agents; D011727:Pyridinolcarbamate